Beauty Farm Medical and Health Industry Inc. (Beauty Farm) disclosed a share repurchase of 30,000 ordinary shares on 14 May 2026. The on-market transaction was executed at prices ranging from HKD 18.59 to HKD 18.91 per share, with an average cost of HKD 18.77, bringing total cash outlay to HKD 0.56 million.

Following the transaction: • Issued shares (excluding treasury shares) fell 0.012 % to 249.52 million. • Treasury shares increased to 2.08 million, keeping total issued shares unchanged at 251.59 million. • Cumulative buybacks under the mandate granted on 27 June 2025 reached 2.08 million shares, equivalent to 0.88 % of the 235.80 million shares outstanding when the mandate was approved.

The company remains authorised to repurchase up to 23.58 million shares under its current mandate. In line with Hong Kong Stock Exchange rules, Beauty Farm faces a moratorium on issuing new shares or selling treasury stock until 13 June 2026.